-
61
Visual Aura Secondary to Supratentorial Lipomatous Meningioma: A Rare Case Report
Published 2022-02-01“…Case Report: A 55-year-old woman presented with a migraine and reported having phosphenes in recent years. Head Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) scans were performed; these showed an extensive hypodense and hypointense formation located in the left parieto-occipital region. …”
Get full text
Article -
62
Clinical experience in the Hospital Central Militar with bilateral deep brain stimulation of ventro-medial globus pallidus in patients with Parkinson's disease
Published 2014-10-01“…The collateral effects such as phosphenes, contralateral paresthesias, deviation of labial commissure and dysarthria, were avoided with the adjustment of stimulation parameters during the surgery. …”
Get full text
Article -
63
Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
Published 2020-12-01“…Only minor side effects, mainly phosphenes were observed in both products. No mortality was demonstrated in both groups. …”
Get full text
Article -
64
Rapidly progressive glomerulopathy in a patient with hepatitis C virus not diagnosed. Case Report.
Published 2024-02-01“…She suddenly presented lower extremity edema, headache, phosphenes, hypertensive uncontrol, hematuria, proteinuria and decreased glomerular filtration. …”
Get full text
Article -
65
Improving the conditions of regional hemodinamics of the eyes as a method of treatment in optic neuropathy at short-sightedness of high degree.
Published 2014-04-01“…Assessing the functional activity of the peripheral parts of the retina , the data to increase sensitivity threshold for phosphenes to 78,54 ± 5,42 mA in the main group and 76,42 ± 3,25 mA in the control prior to treatment. …”
Get full text
Article -
66
Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial
Published 2023-12-01“…However, visual side effects (phosphenes) were reported in 14.3% of patients. <i>Conclusions:</i> Ivabradine is a safe, well-tolerated drug that has shown possible cardioprotective properties reducing the incidence of mild asymptomatic cancer-therapy-induced cardiac dysfunction, characterised by a new rise in troponin concentrations and diminished myocardial performance in anthracycline-treated women with breast cancer and increased heart rate. …”
Get full text
Article